Futures Up, Trump-Xi Talks Calm the Room

🌅 Today's Morning Call

S&P Futures 7,493.75 ▲ +21.50 (+0.29%)	Nasdaq Futures 29,549.75 ▲ +22.50 (+0.08%)	Dow Futures 50,188.00 ▲ +290.00 (+0.58%)
10Y Treasury 4.48% ▲ +0.02%	US Dollar 98.56 ▲ +0.07 (+0.07%)	Bitcoin $79,316 ▲ +$27 (+0.03%)

Good morning! Thursday, May 14th is shaping up to be one of those mornings where the macro picture actually cooperates for once. Futures are pointing higher across the board, with the Dow leading the charge up nearly 290 points in pre-market, as U.S.-China tensions show real signs of cooling after the Trump-Xi summit. From telecom joint ventures to a blockbuster IPO, there is a lot on the table this morning. Here is your full rundown of what matters before the bell.

👀 What to Watch Today

The biggest event to circle on your calendar today is the Cerebras Systems IPO, which is being called the largest public offering of the year. The AI chip designer is set to begin trading Thursday, and given the current appetite for anything touching artificial intelligence, this one will be watched closely from the opening bell.

On the legislative front, the Senate Banking Committee takes up a landmark crypto bill today under Republican leadership. This is a meaningful step forward for digital asset regulation that has been stalled for years. With Bitcoin sitting just above $79,300 and holding steady, the market will be listening carefully to how the committee session unfolds.

Treasury yields are ticking up modestly, with the 10-year at 4.48% and the 30-year pushing above 5.05%. That backdrop keeps the pressure on rate-sensitive sectors, so watch how financials and real estate investment trusts respond once trading kicks off.

Why BofA is "Raiding" this $3.8B Gold Stock [ad]

🌏 Overnight Recap

Overnight, the dominant story was the Trump-Xi meeting and what it signals for U.S.-China relations going forward. Harvard professor Graham Allison, the scholar behind the Thucydides Trap framework, characterized the summit's tone as focused on stabilization rather than resolution, which is still a meaningful shift after nearly a decade of escalating friction. Markets took that as a reason to exhale.

Out of Asia, Foxconn reported an 18.5% jump in first-quarter profit, blowing past analyst estimates. The world's largest contract electronics manufacturer cited strong AI server demand as a key driver, which bodes well for the broader supply chain tied to names like Apple (AAPL) and Nvidia (NVDA). Shares of Foxconn parent companies HNHAF and HNHPF are ones to monitor.

Over in Europe, AstraZeneca (AZN) delivered a positive late-stage trial readout for its cancer drug Imfinzi, showing improved survival rates in muscle-invasive bladder cancer patients. Meanwhile, Burberry (BURBY) posted a 5% sales increase, a quiet but real sign that its turnaround strategy is gaining traction despite a tricky global backdrop.

ALERT: Drop these 5 stocks before the market opens tomorrow! [ad]

📊 Pre-Market Movers

Biogen (BIIB) is in the spotlight for all the wrong reasons this morning after its Alzheimer's drug failed to hit the primary endpoint in a mid-stage clinical trial. Drug trial misses of this nature tend to hit biotech stocks hard at the open, and BIIB is likely to face selling pressure as investors reassess the pipeline.

AstraZeneca (AZN) is on the other end of the spectrum. Positive late-stage data for Imfinzi in bladder cancer patients gives the stock a meaningful catalyst heading into today's session. Late-stage survival data is the gold standard in oncology trials, so this readout carries real weight.

On the telecom side, AT&T (T), T-Mobile (TMUS), and Verizon (VZ) all have a joint venture headline to digest this morning. The plan to pool resources for rural satellite coverage is a long-term play rather than a short-term earnings driver, but it signals a new phase of cooperation that could reshape how the sector allocates capital over the next several years.

Elon Musk, Larry Fink & Brian Armstrong are ALL Piling into This [ad]

🔍 Today's Watchlist

1. Cerebras Systems IPO: The year's biggest public offering hits the tape today. Watch the opening print for AI sector sentiment.
2. Senate crypto bill hearing: The Banking Committee reviews landmark digital asset legislation. COIN and crypto-adjacent names could react.
3. T, TMUS, VZ rural joint venture: Three carriers teaming up on satellite-based rural coverage signals a structural shift worth tracking in telecom.
4. 30-year Treasury at 5.05%: Long-end yields holding above 5% keeps pressure on growth stocks. Watch for any move in either direction.
5. MSFT antitrust probe: The UK CMA opening a formal investigation into Microsoft's software dominance is a slow-burn story with real regulatory tail risk.

🎯 The Morning Playbook

The playbook for today starts with one word: stabilization. The U.S.-China summit framing from analysts is cautiously constructive, and futures are reflecting that. But with yields still elevated and the 30-year above 5%, this is not a market where you want to chase indiscriminately.

The Cerebras IPO is the highest-profile event of the session and will tell you something real about risk appetite for AI names right now. If it prices well and trades up, that is a green light signal for sentiment across the tech sector. If it stumbles out of the gate, take note.

BIIB is worth watching as a reminder that biotech is a binary world, one data readout can erase months of gains. Meanwhile, the crypto bill hearing adds a layer of optionality for digital asset exposure. Stay focused, stay selective, and let the tape confirm before you commit.

This makes me furious [ad]